Page last updated: 2024-08-22

hyaluronoglucosaminidase and Cancer of Head

hyaluronoglucosaminidase has been researched along with Cancer of Head in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (22.22)	18.7374
1990's	3 (33.33)	18.2507
2000's	2 (22.22)	29.6817
2010's	1 (11.11)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Chen, D; Chen, X; Dong, Z; He, X; Li, J; Li, M; Li, T; Liu, Y; Tao, Y; Wang, Y; Zang, S; Zhao, Z	1
Anemone, L; Bongiorno-Borbone, L; Compagnone, M; Fierro, C; Gatti, V; Markert, EK; Mauriello, A; Melino, G; Peschiaroli, A; Presutti, D; Ruberti, G; Vousden, KH; Zhou, H	1
Fisher, P; Franzmann, EJ; Goodwin, WJ; Lokeshwar, VB; Schroeder, GL; Weed, DT	1
Beydoun, B; Biou, C; Illouz, G; Langman, JC; Mokdad, R	1
Klocker, J; Raunik, W; Sabitzer, H; Schumer, J; Wieser, S	2
Csóka, AB; Frost, GI; Gray, JW; Mohapatra, G; Stern, R; Wong, TM	1
Allmayer, H; Klocker, J; Rab, B; Schumer, J; Tidstrand, J	1
Bijman, JT; van den Broek, P; van Rennes, H; Wagener, DJ; Wessels, JM	1

Trials

1 trial(s) available for hyaluronoglucosaminidase and Cancer of Head

Article	Year
Hyaluronidase as additive to induction chemotherapy in advanced squamous cell carcinoma of the head and neck. Cancer letters, 1998, Sep-11, Volume: 131, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Survival Rate; Vindesine	1998

Other Studies

8 other study(ies) available for hyaluronoglucosaminidase and Cancer of Head

Article	Year
Cellular Hypoxia Mitigation by Dandelion-like Nanoparticles for Synergistic Photodynamic Therapy of Oral Squamous Cell Carcinoma. ACS applied materials & interfaces, 2022, Oct-05, Volume: 14, Issue:39 Topics: Adenosine Triphosphate; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; ErbB Receptors; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Hypoxia; Ligands; Micelles; Mouth Neoplasms; Nanogels; Nanoparticles; Oxygen; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Resveratrol; Squamous Cell Carcinoma of Head and Neck	2022
ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America, 2017, 12-12, Volume: 114, Issue:50 Topics: Biomarkers, Tumor; Carcinogenesis; Carcinoma, Squamous Cell; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; HEK293 Cells; Humans; Hyaluronan Receptors; Hyaluronan Synthases; Hyaluronic Acid; Hyaluronoglucosaminidase; Signal Transduction; Transcription Factors; Transcriptional Activation; Tumor Suppressor Proteins	2017
Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. International journal of cancer, 2003, Sep-01, Volume: 106, Issue:3 Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Head and Neck Neoplasms; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Hydrogen-Ion Concentration; Immunoblotting; Mouth; Neoplasm Staging; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sensitivity and Specificity; Tumor Cells, Cultured	2003
[Place of aspiration lipolysis in the surgical treatment of Launois-Bensaude syndrome]. Revue de stomatologie et de chirurgie maxillo-faciale, 1984, Volume: 85, Issue:6 Topics: Adipose Tissue; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Lipomatosis; Male; Middle Aged; Suction; Syndrome	1984
Combined application of cisplatin, vindesine, hyaluronidase and radiation for treatment of advanced squamous cell carcinoma of the head and neck. American journal of clinical oncology, 1995, Volume: 18, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Radiotherapy, High-Energy; Survival Analysis; Vindesine	1995
HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA. Oncogene, 2000, Feb-17, Volume: 19, Issue:7 Topics: Alternative Splicing; Carcinoma, Squamous Cell; Cell Line; Chromosomes, Human, Pair 3; DNA, Complementary; Enzyme Induction; Exons; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Genes, Tumor Suppressor; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Introns; Open Reading Frames; Promoter Regions, Genetic; RNA Precursors; Tumor Cells, Cultured	2000
[Cisplatin, vindesine and hyaluronidase combined with simultaneous radiotherapy of advanced head and neck tumors]. Onkologie, 1990, Volume: 13, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Lymphatic Metastasis; Male; Middle Aged; Pilot Projects; Prospective Studies; Radiotherapy Dosage; Vindesine	1990
Flow cytometric evaluation of cell dispersion from human head and neck tumors. Cytometry, 1985, Volume: 6, Issue:4 Topics: Adult; Aged; Cell Separation; Chlorides; Deoxyribonuclease I; Dithioerythritol; DNA, Neoplasm; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Lithium; Lithium Chloride; Male; Microbial Collagenase; Middle Aged; Pepsin A; Ribonuclease, Pancreatic; Trypsin	1985